• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
GPs’ role in linking patients with the NDIS

GPs’ role in linking patients with the NDIS

The new RACGP resource can help assess patient eligibility for the NDIS and give information on how to access it.


Increase to NDIS price limits good news for rural providers

Increase to NDIS price limits good news for rural providers

The Federal Government has announced a spending boost to the scheme, with particular benefits for service providers in rural and remote areas.


Behind the scenes at the PBAC

Behind the scenes at the PBAC

Outgoing RACGP representative Rashmi Sharma pulls back the curtain after 10 years on the Pharmaceutical Benefits Advisory Committee.


Protecting your practice from a notifiable data breach

Protecting your practice from a notifiable data breach

The RACGP has again collaborated with the Office of the Australian Information Commissioner for Privacy Awareness Week.


Old doc, new data: Canaglifozin

Old doc, new data: Canaglifozin

Can-I-get-a-flozin?  Dr Casey Parker examines new evidence for the diabetes medication.


Metabolic disorder drug listed on the PBS

Metabolic disorder drug listed on the PBS

The listing will save patients with hyperphenylalaninemia more than $90,000 a year.


Government’s NDIS growth figures ‘pretty meaningless’: GP

Government’s NDIS growth figures ‘pretty meaningless’: GP

Dr James Best discusses the gap between the Government’s positive depiction of the NDIS and the experiences of people navigating the scheme.


Potentially ‘life changing’ arthritis drug listed on PBS

Potentially ‘life changing’ arthritis drug listed on PBS

Tofacitinib will be listed despite lingering concerns related to an increased risk of blood clots and potentially death when taken in high doses.


Cheaper treatments for cancer, Parkinson’s and motor neurone patients

Cheaper treatments for cancer, Parkinson’s and motor neurone patients

Changes to the Pharmaceutical Benefits Scheme will see some patients saving up to $300,000 per year.


Important psoriatic arthritis drug listed on the PBS

Important psoriatic arthritis drug listed on the PBS

Ixekizumab is available for patients with the life-long condition, which causes joints to become stiff, painful and often swollen.


  • Previous
  • ...
  • 7
  • 8
  • 9
  • ...
  • Next
Pages: 9 of 11
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807